Practice owners and business leaders across the country are in a quandary as it relates to vaccines made available through emergency use authorization (EUA) for SarsCoV2 and how to respond as an employer. In fact, the ever-changing landscape commonly produces a whipsaw effect with the frequency of policy changes. The original guidance on adverse reaction reporting from the Occupational Safety and Health Administration (OSHA) is important, and since OSHA “pivoted on a dime” overnight in late May, it is possible (perhaps even probable with the increasing lawsuits) that it may return to its original guidance—which was not only legal but practical and ethical as well. Read More